$CUE Cashflow Statement | Understand Stock

$CUE

$18.32 -$0.13 (0.7%) Close

$CUE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Amortization of operating lease right-of-use asset
Decrease in the carrying amount of right-of-use assets
Amortization of premium/discount on purchased securities
Gain on right-of-use asset modification
Loss (gain) on fixed asset disposal
Other non cash charges
Amortization of debt issuance costs
Accretion of final payment of term loan

Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Other assets
Deposits
Foreign withholding tax receivable
Other payable
Accounts payable
Accrued expenses
Research and development contract liability, current portion
Operating lease liability

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Cash received from the sale of property and equipment
Purchases of marketable securities
Redemption of marketable securities
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from ATM offering, net of sales agent commission and fees
Proceeds from issuance of common stock, warrants and pre-funded warrants, net of transaction costs
Issuance of restricted stock awards
Repayment of term loans
Proceeds from the exercise of stock options
Payment of debt issuance costs
Restricted stock awards withheld at vesting to cover taxes
Issuance of common stock upon exercise of warrants and pre-funded warrants, net
Proceeds from borrowing under term loan
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment in accounts payable or accrued expenses
Cash paid for interest
Right-of-use asset and lease liability (new lease)
Operating lease modification
Lease liabilities arising from obtaining right-of-use assets

Comments